Evaluation of the Impact of Cochlear Implants on Cognition in Older Adults
NCT ID: NCT02729402
Last Updated: 2024-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
150 participants
INTERVENTIONAL
2015-11-30
2025-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Cognitive tests will be administered preoperative, and postoperative at 6 and 12 month intervals.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Auditory-Cognitive Training to Optimize Outcomes for Older CI Users
NCT05176561
Cochlear Implantation in the Elderly
NCT05992779
Aging, Cognition, and Hearing Evaluation in Elders Study
NCT02412254
Hearing and Cognition in Aging Adults
NCT06183450
Deafness and Cognition in Middle-aged Adults
NCT05149742
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Pre-operative and 6 and 12 month post-operative cognitive testing will be performed using a battery of tests that will differentiate verbal/auditory and non-verbal cognitive abilities.
Written informed consent will be sought from all individuals who will participate in the proposed project. Consent will be obtained by the principal investigator or key study personnel such as the research coordinator. When a potential participant has been identified, she/he will be visited in person. The participant will be given an overview of the study as well as written material that further explains the study and the responsibilities of the participant. Since some of our participants may have cognitive impairment, we will also make a determination about capacity to provide informed consent. Following presentation of the informed consent document, participants will be asked questions about the study (i.e. purpose, procedures, risks, and benefits). If these questions are adequately answered, then the participant will be judged to have capacity to provide informed consent. However, if these questions are not adequately answered, the participants will not be judged to have this capacity. In these latter cases, assent will be obtained from the participant and informed consent will be obtained from the participant's legally authorized representative (spouse, adult child
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Older Cochlear Implant Subjects
We will assign the study participants to a diagnostic intervention (cognitive testing) before and after their cochlear implant.
Cognitive Testing
We will use a battery of neurocognitive tests to assess cognitive function before and after surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive Testing
We will use a battery of neurocognitive tests to assess cognitive function before and after surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Utah
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Richard Gurgel
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard Gurgel, MD
Role: PRINCIPAL_INVESTIGATOR
University of Utah
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
83983
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.